The Wall Street Journal: Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market

Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.

The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more — and there may not be one.

Share:

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…

Latest News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Financial News

Policy(Required)

Financial News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Policy(Required)